This session will explore the latest innovations in diagnostic techniques for coagulation disorders. Emphasis will be placed on the integration of molecular studies and laboratory innovations to enhance patient outcomes.

This track will delve into the underlying mechanisms of thrombosis and its clinical implications. Discussions will focus on novel therapeutic strategies and their effectiveness in managing thrombotic conditions.

This session will address the importance of patient monitoring in the management of hemostatic disorders. Participants will review current practices and emerging technologies that facilitate real-time assessment of coagulation status.

This track will highlight the bridge between basic research and clinical application in hematology. Presentations will focus on how translational research is shaping new therapeutic approaches for coagulation disorders.

This session will provide insights into the design and outcomes of recent clinical trials targeting coagulation disorders. Experts will discuss challenges faced and future directions for research in this field.

This track will focus on the molecular mechanisms governing hemostasis and their implications for disease. Attendees will explore how molecular studies can inform therapeutic strategies and improve patient care.